Advertisement

Topics

Harbor MedTech, Inc. Company Profile

23:13 EST 14th December 2018 | BioPortfolio


News Articles [452 Associated News Articles listed on BioPortfolio]

VIDEO: Jeff Shuren Talks Breakthrough Bonanza, TPLC And Innovating Safety

In an interview at The MedTech Conference in Philadelphia this week, US FDA device-center Director Jeff Shuren spoke to Medtech...   

Asian Medtech Update: Thai Device Law Latest; National Issues Aired; ASEANMed Seeks Medtech Industry Role At AMDC

This month's Asian Medtech Associations' regulatory networking discussions cover the current progress of the Thai medical device regulation, which must...   

Asian Medtech Update: Thai Device Law Latest, National Issues Aired, ASEANMed Seeks Medtech Industry Role at AMDC

This month's Asian Medtech Associations' regulatory networking discussions cover the current progress of the Thai medical device regulation, which must...   

Global Medtech Guidance Tracker: May 2018

Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-six new guidance documents were posted...   

6 startups enter Boston Scientific-funded medtech accelerator

Six medtech startups have been accepted into startup accelerator gener8tor's second gBETA Medtech accelerator, a Boston Scien -More- 

Twenty-Four Congressional Midterm Races To Watch In US Medtech-Heavy Regions

Medtech firms are accustomed to rooting for House and Senate candidates they have backed in traditionally medtech-facility heavy regions of...   

Medtech M&A hits almost $5B, stocks near record highs

The value of merger and acquisition activity in the medtech industry has reached almost $5 billion so far this year, attribut -More- 

AUDIO: Device Week, Nov. 9, 2018 – What The US Midterms Mean For Medtech

On this week's podcast, David Filmore and Ferdous Al-Faruque discuss the results of this week's midterm elections in the US...    

PubMed Articles [83 Associated PubMed Articles listed on BioPortfolio]

New Medtech Code of Ethics and Cardiology.

Influence of ship emissions on NO, SO, O and PM concentrations in a North-Sea harbor in France.

The influence of in-port ship emissions on gases and PM concentrations has been estimated in the port city of Calais, northern France, one of the busiest harbor in Europe, with numerous rotations of f...

Characteristics of PM from ship emissions and their impacts on the ambient air: A case study in Yangshan Harbor, Shanghai.

The rapid development of ports in China over the last two decades has had inevitable consequences on the ambient air quality in coastal areas and harbors. For mitigation strategies and monitoring aims...

Introduction to the special issue "Cold Spring Harbor Asia Conference on Mitochondria".

Recommended Reading from the Harbor-UCLA Medical Center Fellows.

Clinical Trials [60 Associated Clinical Trials listed on BioPortfolio]

Multi-center Trial of Percutaneous Pulmonary Valve Implantation With Venus-p

Venus-P Valve (Venus Medtech, Shanghai, China) is the first self-expandable interventional Pulmonary Valve, which is composed of a Nitinol multilevel support frame with a tri-leaflet porci...

Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas

This is a study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and anti-tumor activity of DS-1001b in patients with gliomas that harbor IDH1-R132 mutation...

Capmatinib in Patients With Non-small Cell Lung Cancer Harboring cMET exon14 Skipping Mutation

This study is a phase II, single-arm, open label study under an umbrella trial for NSCLC. This clinical study is targeted for the patients who harbor exon 14 skipping mutation of MET and a...

Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation

The purpose of this Phase I, multicenter study is to evaluate the safety, pharmacokinetics, pharmacodynamics and clinical activity of AG-881 in advanced hematologic malignancies that harbo...

Photodisinfection for the Decolonization of Staphylococcus Aureus in Hemodialysis Patients

The purpose of the study is to evaluate whether PDT (MRSAid™) is effective in eradicating SA from hemodialysis patients who are known to harbor this organism inside their nose.

Companies [86 Associated Companies listed on BioPortfolio]

Harbor MedTech, Inc.

MedTech Innovator

Based in Los Angeles, Calif., MedTech Innovator is the premier nonprofit startup accelerator in the medical technology industry. Our mission is to improve the lives of patients by...

MedTech Media

MedTech Media (www.medtechmedia.com) is a privately-held integrated media company based in New Gloucester, Maine. Offering a comprehensive suite of focused news content, MedTech ...

Harbor BioSciences, Inc.

Harbor BioSciences is a development-stage company with two product candidates in clinical trials: Apoptone (HE3235), in the cohort expansion portion of a Phase I/IIa trial of patients with late-stage ...

BioSupplyNet

BioSupplyNet is owned and operated by Cold Spring Harbor Laboratory Press which is the largest of the five education divisions of Cold Spring Harbor Laboratory, New York. The Press assists the advance...

More Information about "Harbor MedTech, Inc." on BioPortfolio

We have published hundreds of Harbor MedTech, Inc. news stories on BioPortfolio along with dozens of Harbor MedTech, Inc. Clinical Trials and PubMed Articles about Harbor MedTech, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Harbor MedTech, Inc. Companies in our database. You can also find out about relevant Harbor MedTech, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record